Literature DB >> 8648698

Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.

L Zhang1, S B Simpson, C M Stoltzfus.   

Abstract

All retroviruses require both unspliced and spliced RNA for a productive infection. One mechanism by which Rous sarcoma virus achieves incomplete splicing involves suboptimal env and src 3' splice sites. We have previously shown that mutagenesis of the nonconsensus src polypyrimidine tract to a 14-nucleotide uninterrupted polypyrimidine tract results in an oversplicing phenotype and a concomitant defective replication in permissive chicken embryo fibroblasts. In this report, we show that splicing at the src 3' splice site (3'ss) is further negatively regulated by the suppressor of src splicing cis element which is located approximately 100 nucleotides upstream of the src 3'ss. The increase in splicing at the src 3'ss results in a corresponding increase in splicing at a cryptic 5'ss within the env gene. Two classes of replication-competent revertants of the src oversplicing mutant (pSAP1) were produced after infection, and these mutants were characterized by molecular cloning and sequence analysis. Class I revertants are transformation-defective revertants in which the src 3'ss and the src gene are deleted by homologous recombination at several different sites within the imperfect direct repeat sequences that flank the src gene. Cells infected with these transformation-defective revertants produce lower levels of virus particles than cells infected with the wild-type virus. Class II revertants bear small deletions in the region containing the branchpoint sequence or polypyrimidine tract of the src 3'ss. Insertion of these mutated sequences into pSAP1 restored inefficient splicing at the src 3'ss and efficient replication in chicken embryo fibroblasts. All of these mutations caused reduced splicing at the src 3'ss when they were tested in an in vitro splicing system. These results indicate that maintenance of a weak src 3'ss is necessary for efficient Rous sarcoma virus replication.

Entities:  

Mesh:

Year:  1996        PMID: 8648698      PMCID: PMC190239     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The organization of 3' splice-site sequences in mammalian introns.

Authors:  R Reed
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

2.  Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer.

Authors:  G A Pulsinelli; H M Temin
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.

Authors:  M T McNally; R R Gontarek; K Beemon
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

4.  Mechanisms of alternative pre-mRNA splicing.

Authors:  T Maniatis
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

5.  The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA.

Authors:  X D Fu; R A Katz; A M Skalka; T Maniatis
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

6.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.

Authors:  S L Berberich; C M Stoltzfus
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions.

Authors:  V K Pathak; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 8.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

9.  Mammalian U2 snRNP has a sequence-specific RNA-binding activity.

Authors:  K K Nelson; M R Green
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

10.  Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing.

Authors:  J Wu; J L Manley
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

View more
  6 in total

1.  A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.

Authors:  M P Wentz; B E Moore; M W Cloyd; S M Berget; L A Donehower
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  RNA processing control in avian retroviruses.

Authors:  Mark T McNally
Journal:  Front Biosci       Date:  2008-05-01

3.  Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.

Authors:  Z Si; B A Amendt; C M Stoltzfus
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

4.  Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle.

Authors:  S B Simpson; L Zhang; R C Craven; C M Stoltzfus
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.

Authors:  L M McNally; M T McNally
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Structural and functional analysis of the Rous Sarcoma virus negative regulator of splicing and demonstration of its activation by the 9G8 SR protein.

Authors:  Aileen Bar; Virginie Marchand; Georges Khoury; Natacha Dreumont; Annie Mougin; Nathalie Robas; James Stévenin; Athanase Visvikis; Christiane Branlant
Journal:  Nucleic Acids Res       Date:  2010-12-22       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.